Bbva Compass Bancshares Inc. decreased its stake in shares of Henry Schein Inc. (NASDAQ:HSIC) by 5.5% during the second quarter, Holdings Channel reports. The firm owned 16,412 shares of the company’s stock after selling 963 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Henry Schein were worth $2,902,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of the stock. Moody Lynn & Lieberson LLC increased its position in shares of Henry Schein by 111.8% in the second quarter. Moody Lynn & Lieberson LLC now owns 6,639 shares of the company’s stock valued at $1,174,000 after buying an additional 3,505 shares during the period. BP PLC bought a new position in Henry Schein during the second quarter worth about $1,768,000. Sumitomo Mitsui Asset Management Company LTD increased its position in Henry Schein by 0.9% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 6,312 shares of the company’s stock worth $1,115,000 after buying an additional 54 shares during the last quarter. Henderson Group PLC increased its position in Henry Schein by 74.7% in the second quarter. Henderson Group PLC now owns 400,128 shares of the company’s stock worth $70,741,000 after buying an additional 171,078 shares during the last quarter. Finally, Essex Financial Services Inc. bought a new position in Henry Schein during the second quarter worth about $203,000. 92.03% of the stock is owned by hedge funds and other institutional investors.
Henry Schein Inc. (NASDAQ:HSIC) traded up 0.09% during midday trading on Monday, hitting $153.50. 368,763 shares of the stock were exchanged. The firm’s 50 day moving average price is $162.17 and its 200 day moving average price is $170.06. Henry Schein Inc. has a 12 month low of $142.64 and a 12 month high of $183.00. The company has a market cap of $12.56 billion, a PE ratio of 26.00 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.63 by $0.01. The company earned $2.87 billion during the quarter, compared to analysts’ expectations of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.46 EPS. On average, equities research analysts forecast that Henry Schein Inc. will post $6.57 earnings per share for the current fiscal year.
A number of research firms recently issued reports on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday. Robert W. Baird downgraded shares of Henry Schein from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $176.00 to $164.00 in a research note on Friday. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target for the company in a research note on Tuesday, October 11th. Finally, Bank of America Corp. initiated coverage on shares of Henry Schein in a research note on Monday, September 12th. They issued a “buy” rating and a $185.00 price target for the company. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. Henry Schein currently has an average rating of “Hold” and an average price target of $159.50.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of the business’s stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $164.03, for a total value of $554,585.43. Following the completion of the sale, the director now directly owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.27% of the stock is currently owned by company insiders.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.